Pages that link to "Q44550733"
Jump to navigation
Jump to search
The following pages link to The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease (Q44550733):
Displaying 50 items.
- Adverse effects of biologics: a network meta-analysis and Cochrane overview (Q24234197) (← links)
- Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors (Q24306707) (← links)
- Lung inflammation caused by inhaled toxicants: a review (Q26744356) (← links)
- Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease (Q26786229) (← links)
- Muscle function in COPD: a complex interplay (Q26865732) (← links)
- Heterogeneity of lung mononuclear phagocytes in chronic obstructive pulmonary disease (Q27014453) (← links)
- Advances in understanding COPD (Q28074701) (← links)
- Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease (Q28761895) (← links)
- What drives the peripheral lung-remodeling process in chronic obstructive pulmonary disease? (Q33518335) (← links)
- Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease (Q33523967) (← links)
- Cytokine inhibition in the treatment of COPD. (Q33568552) (← links)
- Chronic obstructive pulmonary disease: towards pharmacogenetics (Q33600138) (← links)
- p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice (Q33624820) (← links)
- Influencing the decline of lung function in COPD: use of pharmacotherapy (Q33966001) (← links)
- Development and characterization of a long-term murine model of Streptococcus pneumoniae infection of the lower airways. (Q34058974) (← links)
- Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM. (Q34100348) (← links)
- Role of Th17 Cell and Autoimmunity in Chronic Obstructive Pulmonary Disease (Q34127425) (← links)
- Pharmacological characterisation of anti-inflammatory compounds in acute and chronic mouse models of cigarette smoke-induced inflammation (Q34198921) (← links)
- Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary (Q34550471) (← links)
- Compartment differences of inflammatory activity in chronic obstructive pulmonary disease (Q34570194) (← links)
- Hypoxemia in patients with COPD: cause, effects, and disease progression (Q35023212) (← links)
- Update on Pharmaceutical and Minimally Invasive Management Strategies for Chronic Obstructive Pulmonary Disease (Q35028812) (← links)
- Tumour necrosis factor-α regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-κB and AP-1. (Q35108937) (← links)
- A novel nonhuman primate model of cigarette smoke-induced airway disease (Q35143749) (← links)
- COPD association and repeatability of blood biomarkers in the ECLIPSE cohort (Q35637295) (← links)
- Novel aspects of pathogenesis and regeneration mechanisms in COPD (Q35665638) (← links)
- Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease (Q35779864) (← links)
- A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease (Q35838507) (← links)
- Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer (Q35897669) (← links)
- Control of Mycobacterial Infections in Mice Expressing Human Tumor Necrosis Factor (TNF) but Not Mouse TNF. (Q38637483) (← links)
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007 (Q36171750) (← links)
- Pathological networking: a new approach to understanding COPD. (Q36225899) (← links)
- The rs361525 polymorphism does not increase production of tumor necrosis factor alpha by monocytes from alpha-1 antitrypsin deficient subjects with chronic obstructive pulmonary disease - a pilot study (Q36336165) (← links)
- TNF-α is associated with loss of lean body mass only in already cachectic COPD patients (Q36367744) (← links)
- Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD. (Q36426923) (← links)
- Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype (Q36675976) (← links)
- Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines (Q36724093) (← links)
- Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study (Q36732429) (← links)
- The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiency (Q36782392) (← links)
- Update in chronic obstructive pulmonary disease 2006. (Q36838782) (← links)
- Clinical pharmacokinetics and use of infliximab (Q36892770) (← links)
- Acute pulmonary lipopolysaccharide tolerance decreases TNF-alpha without reducing neutrophil recruitment. (Q36902210) (← links)
- Aspects on pathophysiological mechanisms in COPD. (Q36909567) (← links)
- What have we learned from large drug treatment trials in COPD? (Q36926626) (← links)
- COPD exacerbations: defining their cause and prevention (Q36926629) (← links)
- Cardiovascular risk in chronic obstructive pulmonary disease (Q36944067) (← links)
- The cytokine network in asthma and chronic obstructive pulmonary disease (Q36955575) (← links)
- Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease (Q36956720) (← links)
- Targeting TNF-alpha: a novel therapeutic approach for asthma (Q37013367) (← links)
- Host defenses against respiratory tract infection: implications for anti-inflammatory drug development and treatment (Q37030665) (← links)